Page last updated: 2024-09-03

y 27632 and Glaucoma, Open-Angle

y 27632 has been researched along with Glaucoma, Open-Angle in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Fujimoto, T; Inoue, T; Inoue-Mochita, M1
Chattopadhyay, P; Das, P; Kamboj, DV; Kumar, M; Niri, P; Polopalli, S; Saha, A1
Hikage, F; Ida, Y; Ohguro, H; Ota, C1
Annabi, N; Bagué, T; Ganapathy, PS; Herberg, S; Kirschner, A; Li, H; Patteson, AE; Roberts, H; Stamer, WD; Strat, AN; Weisenthal, RW1

Reviews

1 review(s) available for y 27632 and Glaucoma, Open-Angle

ArticleYear
ROCK Inhibitors as an Alternative Therapy for Corneal Grafting: A Systematic Review.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2023, Volume: 39, Issue:9

    Topics: Corneal Injuries; Corneal Transplantation; Endothelium, Corneal; Glaucoma, Open-Angle; Humans; rho-Associated Kinases

2023

Other Studies

3 other study(ies) available for y 27632 and Glaucoma, Open-Angle

ArticleYear
A ROCK inhibitor suppresses the transforming growth factor-beta-2-induced endothelial-mesenchymal transition in Schlemm's canal endothelial cells.
    Scientific reports, 2023, 06-14, Volume: 13, Issue:1

    Topics: Endothelial Cells; Glaucoma, Open-Angle; Humans; rho-Associated Kinases; Schlemm's Canal; Transforming Growth Factor beta2; Transforming Growth Factors

2023
ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM).
    Scientific reports, 2020, 11-20, Volume: 10, Issue:1

    Topics: Amides; Antihypertensive Agents; Cell Culture Techniques; Cell Line; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Isoquinolines; Microscopy, Electron, Scanning; Optic Nerve Diseases; Organoids; Pyridines; rho-Associated Kinases; Spheroids, Cellular; Sulfonamides; Trabecular Meshwork; Transforming Growth Factor beta2

2020
A tissue-engineered human trabecular meshwork hydrogel for advanced glaucoma disease modeling.
    Experimental eye research, 2021, Volume: 205

    Topics: Actins; Aged, 80 and over; Amides; Biomimetic Materials; Cytoskeletal Proteins; Dexamethasone; Elastin; Enzyme Inhibitors; Eye Proteins; Female; Gene Expression Regulation; Glaucoma, Open-Angle; Glucocorticoids; Glycoproteins; Humans; Hydrogels; Immunohistochemistry; Models, Biological; Pyridines; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; Tissue Engineering; Trabecular Meshwork

2021